Abstract
The great majority of headaches a physician treats in office practice can be divided into two main categories, muscular contraction headache of tension type and vascular headaches of the migraine type.
The most satisfactory symptomatic therapy for tension headache is by the use of a nonnarcotic analgesic agent combined with a tranquilizer or sedative. On the other hand, symptomatic relief of migraine is best obtained by the use of a suppository of ergotamine tartrate and caffeine combined with an antiemetic or antispasmodic.
Interval treatment of patients with tension and migraine headache centers on helping the patient understand his emotional problems. Prophylactic drug therapy for patients with tension headache includes the limited use of tranquilizers and sedatives. Recently, striking benefits in some patients with migraine have been achieved by the prophylactic use of the antiserotonin drug methysergide (UML 491).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CHAPMAN L. F., RAMOS A. O., GOODELL H., SILVERMAN G., WOLFF H. G. A humoral agent implicated in vascular headache of the migraine type. Arch Neurol. 1960 Sep;3:223–229. doi: 10.1001/archneur.1960.00450030001001. [DOI] [PubMed] [Google Scholar]
- FRIEDMAN A. P. Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache. Angiology. 1960 Aug;11:364–366. doi: 10.1177/000331976001100409. [DOI] [PubMed] [Google Scholar]
- FRIEDMAN A. P. Evaluation of nonnarcotic chemical agents in headaches. Ann N Y Acad Sci. 1960 Mar 30;86:216–225. doi: 10.1111/j.1749-6632.1960.tb42802.x. [DOI] [PubMed] [Google Scholar]
- FRIEDMAN A. P., VON STORCH T. J., MERRITT H. H. Migraine and tension headaches; a clinical study of two thousand cases. Neurology. 1954 Oct;4(10):773–788. doi: 10.1212/wnl.4.10.773. [DOI] [PubMed] [Google Scholar]
- TUNIS M. M., WOLFF H. G. Studies on headache; cranial artery vasoconstriction and muscle contraction headache. AMA Arch Neurol Psychiatry. 1954 Apr;71(4):425–434. [PubMed] [Google Scholar]